Texas OK's $50 Million for Ibogaine Research
When Gov. Greg Abbott of Texas approved legislation this week to spend $50 million in state money researching ibogaine, a powerful psychedelic, he put the spotlight on a promising, still illegal drug that has shown promise in treating opioid addiction, traumatic brain injury and depression.
Interest in ibogaine therapy has surged in recent years, driven in large part by veterans who have had to travel to other countries for the treatment.
The measure, which passed the Texas Legislature with bipartisan support, seeks to leverage an additional $50 million in private investment to fund clinical trials that supporters hope will provide a pathway for ibogaine therapy to win approval from the Food and Drug Administration, a process that could take years.
The legislation directs the state to work with Texas universities and hospitals and tries to ensure that the state retains a financial stake in any revenue from the drug's development.
'You can't put a price on a human life, but if this is successful and ibogaine becomes commercialized, it will help people all across the country and provide an incredible return on investment for the people of Texas,' said State Senator Tan Parker, a Republican who sponsored the bill.
The initiative, one of the largest government investments in psychedelic medicine to date, is a watershed moment for a field that continues to gain mainstream acceptance. Regulated psilocybin clinics have opened in Oregon and Colorado, and ketamine has become widely available across the country as a treatment for depression and anxiety.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Cause of Death Revealed for Daughter Who Died During Trail Hike with Her Dad
The Maine Office of the Chief Medical Examiner has reportedly released the cause of death for hiker Esther Keiderling, who died in early June during a Mount Katahdin trail hike The 28-year-old hiker's cause of death was listed as blunt force trauma, per News 10 ABC, WGME CBS 13 and WABI 5 Her dad Tim Keiderling's cause of death has not yet been listedMore details are emerging in the deaths of Tim and Esther Keiderling, the dad and daughter who died on a trail hike in Maine this month. A medical examiner revealed that the cause of death for Esther, 28, was from blunt force trauma, while father's cause of death has not yet been shared, reported News 10 ABC, WGME CBS 13 and WABI 5. Esther may have slid down the terrain with an uncontrollable force as her remains were found in a snow covered boulder field below the Cathedral Cut-off Trail, News Center Maine reported. PEOPLE reached out to the Maine Office of the Chief Medical Examiner on June 14 for additional details, but did not receive an immediate response. News Center Maine added that witnesses told investigators that Tim, 58, and Esther, were continuing their climb when harsh weather conditions, including wind gusts of up to 40 miles per hour. A mixture of sleet, rain and snow reportedly also impacted the father and daughter as wind chills dropped into the teens, and hypothermia was a high risk. Investigators also said that the Keiderlings did reach the summit of Saddle Trail but veered off course during their descent, the outlet and Esther, both of Ulster Park, N.Y., were last seen on June 1 at around 10:15 a.m. local time. The duo had set out from the Abol Campground to hike Mount Katahdin, according to a statement from the Maine Department of Inland Fisheries and Wildlife. Days later, on June 3, authorities updated the statement, writing that a Maine Warden Service K9 search team found Tim's body near the summit of the mountain, but his daughter remained missing. The organization updated the statement again the following day on June 4, announcing that searchers had found Esther's body. Tim's brother-in-law Heinrich Arnold posted on the family's New York-based church, that the deaths had been "difficult to fully grasp." He continued, "Both were taken from us far too soon, and we are all left asking: 'Why?' ' Arnold thanked the community for the outpouring of support and shared what was giving the family solace as they mourned the father of six and Esther. "One comfort to the family is knowing that Tim and Esther were doing something they both were passionate about: being near to God, surrounded by expansive views and visions, immersed in nature, in the raw and wild beauty of creation," Arnold said. The Maine Department of Inland Fisheries and Wildlife did not respond to PEOPLE's request for further updates on June 14. Read the original article on People
Yahoo
37 minutes ago
- Yahoo
Erin Moriarty Announces Graves' Disease Diagnosis: ‘Go Get Checked'
Erin Moriarty has been diagnosed with Graves' disease, the actress announced on Instagram Friday. Moriarty shared a text message in which she detailed her symptoms and a series of selfies along with a caption in which she encouraged her followers to 'go get checked' if they experience similar symptoms. 'Autoimmune disease manifests differently in everybody/every body. Your experience will be different from mine. My experience will be different from yours. Perhaps greatly, perhaps minutely,' Moriartiy wrote. Graves' disease is an autoimmune disorder that impacts the thyroid. 'One thing I can say: If I hadn't chalked it all up to stress and fatigue, I would've caught this sooner. A month ago, I was diagnosed with Graves' disease. Within 24 hours of beginning treatment, I felt the light coming back on. It's been increasing in strength ever since. If yours is dimming, even slightly, go get checked. Don't 'suck it up' and transcend suffering; you deserve to be comfy. S–t's hard enough as is.' Moriarty has starred on 'The Boys' since 2019, and the final season of the series is set to air next year. The post Erin Moriarty Announces Graves' Disease Diagnosis: 'Go Get Checked' appeared first on TheWrap.
Forbes
2 hours ago
- Forbes
Time For Medicare Advantage Leaders—Including Me—To Eat Our Own Cooking
Dr. Oz just turned 65 and became a Medicare beneficiary. Everyone who operates a Medicare plan ... More should be required to be one as well. In every industry, the best leaders live the experience of the customer. Car executives drive their own vehicles. Airline leaders occasionally fly coach. Restauranteurs eat from their own kitchen. But in healthcare—and specifically in Medicare Advantage (MA), which now serves more than 30 million Americans—the leaders designing these plans rarely, if ever, use them themselves. This disconnect breeds an empathy gap between decision-makers and the seniors whose lives and well-being depend on these products. It's time to close that gap. As Dr. Mehmet Oz turns 65 and qualifies for Medicare, he is in a unique position to lead the charge in fixing this blind spot. But I'm not letting myself off the hook either. As a current CEO of company that sells Medicare Advantage plans, I am proposing a standard that would apply to me and every other leader in this space: if you run a Medicare Advantage plan—or sit on its executive team that runs these plans—you should be required to enroll in that plan. No carve-outs. No executive-only exemptions. No platinum side-door coverage. For those of us under 65, the proposal would also require a structural change: expanding Medicare eligibility to allow MA plan executives early, voluntary enrollment in their own plans. We should not be allowed to claim ignorance or detachment simply because of our age. I want to be clear: if such an early-enrollment window existed, I would enroll myself. I should have to live under the same benefit design, customer service, and network constraints as every other member. Leaders like me—and my peers across the industry—must eat our own cooking.A Modest But Necessary Reform The proposal is simple but powerful: 1. All managed care CEOs and executive teams must enroll in their own MA plan. 2. Congress and CMS should create a new category of Medicare eligibility that allows executives under 65 to voluntarily enroll in their own MA plans in a 'test user' capacity. This is the only way for leadership to truly understand the member experience. 3. No waivers, no special coverage allowances. The goal is to force leadership to live the true plan reality: the prior authorizations, the formularies, the network restrictions, the call centers, the appeals It Matters—for Me, and for the Industry I don't make this proposal lightly—because it would apply to me, too. If this became law or industry standard tomorrow, I would sign up. And I believe most honest leaders would welcome the clarity and accountability it would bring. Here's why it matters:- Operational Truth: You only truly understand the friction points—customer service delays, billing errors, prescription denials—if you live them yourself.- Accountability: Plan leaders would no longer tolerate broken systems they themselves have to endure.- Culture Change: A company where the C-suite shares the same risks and frustrations as members cannot help but become more consumer-focused.- Public Trust: Medicare Advantage is under increasing scrutiny from policymakers and the public. This move would send a clear, ethical signal: we stand behind what we sell.- Policy Innovation: The best ideas for simplifying prior authorization, improving networks, and reducing out-of-pocket costs would come not from distant consultants—but from firsthand More 'Not For Me' Products Too much of healthcare is designed by people who never have to use it. Too many decisions are made in corporate conference rooms far removed from the lived experience of real patients. If Medicare Advantage is the future of healthcare for seniors—as so many believe—its architects must also live that future. That includes Dr. Oz. That includes every MA CEO. And that includes me. It's time for all of us to eat our own cooking.
